Other Species / Isoforms
  MARCKS (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K11-ub
QFSKTAAkGEAAAER
0 27
MARCKS (human) QFSKTAAkGEAAAER K11-ub
MARCKS (mouse) QFSKTAAkGEAtAER K11-ub
MARCKS (rat) QFSKTAAKGEAAAER K11
MARCKS (chicken) QFSKTAAKGEAAAEK K11
MARCKS (cow) QFSKTAAKGEATAER K11
A15
TAAkGEAAAERPGEA
0 2
MARCKS (human) TAAkGEAAAERPGEA A15
MARCKS (mouse) TAAkGEAtAERPGEA T15-p
MARCKS (rat) TAAKGEAAAERPGEA A15
MARCKS (chicken) TAAKGEAAAEKPGEA A15
MARCKS (cow) TAAKGEATAERPGEA T15
S26-p
PGEAAVAssPskANG
0 16
MARCKS (human) PGEAAVAssPskANG S26-p
MARCKS (mouse) PGEAAVAssPsKANG S26-p
MARCKS (rat) PGEAAVAssPsKANG S26-p
MARCKS (chicken) KPGEAVAAsPSKANG A25
MARCKS (cow) PGEAAVASSPSKANG S26
S27-p
GEAAVAssPskANGQ
Upstream
5 57
Treatment
  • EGF
  • nocodazole
MARCKS (human) GEAAVAssPskANGQ S27-p
MARCKS (mouse) GEAAVAssPsKANGQ S27-p
MARCKS (rat) GEAAVAssPsKANGQ S27-p
MARCKS (chicken) PGEAVAAsPSKANGQ S26-p
MARCKS (cow) GEAAVASSPSKANGQ S27
S29-p
AAVAssPskANGQEN
Upstream
0 28
Treatment
  • nocodazole
MARCKS (human) AAVAssPskANGQEN S29-p
MARCKS (mouse) AAVAssPsKANGQEN S29-p
MARCKS (rat) AAVAssPsKANGQEN S29-p
MARCKS (chicken) EAVAAsPSKANGQEN S28
MARCKS (cow) AAVASSPSKANGQEN S29
K30-ub
AVAssPskANGQENG
0 3
MARCKS (human) AVAssPskANGQENG K30-ub
MARCKS (mouse) AVAssPsKANGQENG K30
MARCKS (rat) AVAssPsKANGQENG K30
MARCKS (chicken) AVAAsPSKANGQENG K29
MARCKS (cow) AVASSPSKANGQENG K30
N42
ENGHVKVNGDAsPAA
0 1
MARCKS (human) ENGHVKVNGDAsPAA N42
MARCKS (mouse) ENGHVKVnGDAsPAA N42-ng
MARCKS (rat) ENGHVKVNGDAsPAA N42
MARCKS (chicken) ENGHVKVNGDASPAA N41
MARCKS (cow) ENGHVKVNGDASPAA N42
S46-p
VKVNGDAsPAAAEsG
Upstream
3 40
Kinase, in vitro:
  • ERK1 (human)
  • ERK2 (human)
  • JNK1 (human)
  • JNK2 (human)
Treatment
  • nocodazole
MARCKS (human) VKVNGDAsPAAAEsG S46-p
MARCKS (mouse) VKVnGDAsPAAAEPG S46-p
MARCKS (rat) VKVNGDAsPAAAEPG S46-p
MARCKS (chicken) VKVNGDASPAAAEAG S45
MARCKS (cow) VKVNGDASPAAAEPG S46
S52-p
AsPAAAEsGAkEELQ
0 2
MARCKS (human) AsPAAAEsGAkEELQ S52-p
MARCKS (mouse) AsPAAAEPGAKEELQ P52
MARCKS (rat) AsPAAAEPGAKEELQ P52
MARCKS (chicken) ASPAAAEAGKEEVQA A51
MARCKS (cow) ASPAAAEPGAKEELQ P52
K55-ub
AAAEsGAkEELQANG
0 1
MARCKS (human) AAAEsGAkEELQANG K55-ub
MARCKS (mouse) AAAEPGAKEELQAnG K55
MARCKS (rat) AAAEPGAKEELQANG K55
MARCKS (chicken) PAAAEAGKEEVQANG K53
MARCKS (cow) AAAEPGAKEELQANG K55
N61
AkEELQANGsAPAAD
0 1
MARCKS (human) AkEELQANGsAPAAD N61
MARCKS (mouse) AKEELQAnGsAPAAD N61-ng
MARCKS (rat) AKEELQANGsAPAAD N61
MARCKS (chicken) GKEEVQANGSAPAEE N59
MARCKS (cow) AKEELQANGSAPAAD N61
S63-p
EELQANGsAPAADkE
0 11
MARCKS (human) EELQANGsAPAADkE S63-p
MARCKS (mouse) EELQAnGsAPAADKE S63-p
MARCKS (rat) EELQANGsAPAADKE S63-p
MARCKS (chicken) EEVQANGSAPAEETG S61
MARCKS (cow) EELQANGSAPAADKE S63
K69-ub
GsAPAADkEEPAAAG
0 1
MARCKS (human) GsAPAADkEEPAAAG K69-ub
MARCKS (mouse) GsAPAADKEEPASGs K69
MARCKS (rat) GsAPAADKEEPAsGG K69
MARCKS (chicken) GSAPAEETGKEEAAS T67
MARCKS (cow) GSAPAADKEEPAAAG K69
A74
ADkEEPAAAGsGAAs
0 1
MARCKS (human) ADkEEPAAAGsGAAs A74
MARCKS (mouse) ADKEEPASGsAAtPA S74
MARCKS (rat) ADKEEPAsGGAAtPA S74-p
MARCKS (chicken) gap -
MARCKS (cow) ADKEEPAAAGSGAAS A74
S77-p
EEPAAAGsGAAsPsA
Upstream
0 13
Treatment
  • nocodazole
MARCKS (human) EEPAAAGsGAAsPsA S77-p
MARCKS (mouse) KEEPASGsAAtPAAA S76-p
MARCKS (rat) gap -
MARCKS (chicken) gap -
MARCKS (cow) EEPAAAGSGAASPAA S77
S81-p
AAGsGAAsPsAAEkG
Upstream
0 22
Treatment
  • EGF
  • nocodazole
MARCKS (human) AAGsGAAsPsAAEkG S81-p
MARCKS (mouse) PASGsAAtPAAAEKD T79-p
MARCKS (rat) PAsGGAAtPAAADKD T79-p
MARCKS (chicken) gap -
MARCKS (cow) AAGSGAASPAAAEKD S81
S83-p
GsGAAsPsAAEkGEP
0 2
MARCKS (human) GsGAAsPsAAEkGEP S83-p
MARCKS (mouse) SGsAAtPAAAEKDEA A81
MARCKS (rat) sGGAAtPAAADKDEA A81
MARCKS (chicken) gap -
MARCKS (cow) GSGAASPAAAEKDEP A83
K87-ub
AsPsAAEkGEPAAAA
0 2
MARCKS (human) AsPsAAEkGEPAAAA K87-ub
MARCKS (mouse) AtPAAAEKDEAAAAT K85
MARCKS (rat) AtPAAADKDEAAAAP K85
MARCKS (chicken) gap -
MARCKS (cow) ASPAAAEKDEPAAAA K87
S101-p
AAPEAGAsPVEkEAP
Upstream
0 36
Treatment
  • angiotensin_2
  • EGF
  • lapatinib
  • nocodazole
  • selumetinib
  • U0126
  • vemurafenib
MARCKS (human) AAPEAGAsPVEkEAP S101-p
MARCKS (mouse) gap -
MARCKS (rat) AAPEPGAATADKEAA A97
MARCKS (chicken) gap -
MARCKS (cow) AAPDAGASPVEKEAP S100
K105-ub
AGAsPVEkEAPAEGE
0 2
MARCKS (human) AGAsPVEkEAPAEGE K105-ub
MARCKS (mouse) PGAGAADKEAAEAEP K101
MARCKS (rat) PGAATADKEAAEAEP K101
MARCKS (chicken) SSEPASEKEAAEAES K81
MARCKS (cow) AGASPVEKEAPVEGE K104
G117
EGEAAEPGsPtAAEG
0 5
MARCKS (human) EGEAAEPGsPtAAEG G117
MARCKS (mouse) EAEPAEPssPAAEAE S112-p
MARCKS (rat) EAEPAEPGsPSAETE G112
MARCKS (chicken) EAESTEPASPAEGEA A92
MARCKS (cow) EGEAAEPGSPTAAEG G116
S118-p
GEAAEPGsPtAAEGE
Upstream
0 32
Treatment
  • EGF
  • selumetinib
  • U0126
  • vemurafenib
MARCKS (human) GEAAEPGsPtAAEGE S118-p
MARCKS (mouse) AEPAEPssPAAEAEG S113-p
MARCKS (rat) AEPAEPGsPSAETEG S113-p
MARCKS (chicken) AESTEPASPAEGEAS S93
MARCKS (cow) GEAAEPGSPTAAEGE S117
T120-p
AAEPGsPtAAEGEAA
Upstream
0 8
Treatment
  • LPA
MARCKS (human) AAEPGsPtAAEGEAA T120-p
MARCKS (mouse) gap -
MARCKS (rat) PAEPGsPSAETEGAs S115
MARCKS (chicken) gap -
MARCKS (cow) AAEPGSPTAAEGEAA T119
S128-p
AAEGEAAsAAsstss
Upstream
0 9
Treatment
  • angiotensin_2
MARCKS (human) AAEGEAAsAAsstss S128-p
MARCKS (mouse) AAEAEGAsAsstssP S122-p
MARCKS (rat) SAETEGAsASSTSSP S122-p
MARCKS (chicken) gap -
MARCKS (cow) AAEGEAASAASSTSS S127
S131-p
GEAAsAAsstssPKA
Upstream
0 6
Treatment
  • angiotensin_2
MARCKS (human) GEAAsAAsstssPKA S131-p
MARCKS (mouse) EAEGAsAsstssPKA S124-p
MARCKS (rat) ETEGAsASSTSSPKA S124
MARCKS (chicken) gap -
MARCKS (cow) GEAASAASSTSSPKA S130
S132-p
EAAsAAsstssPKAE
1 6
MARCKS (human) EAAsAAsstssPKAE S132-p
MARCKS (mouse) AEGAsAsstssPKAE S125-p
MARCKS (rat) TEGAsASSTSSPKAE S125
MARCKS (chicken) gap -
MARCKS (cow) EAASAASSTSSPKAE S131
T133-p
AAsAAsstssPKAED
0 4
MARCKS (human) AAsAAsstssPKAED T133-p
MARCKS (mouse) EGAsAsstssPKAED T126-p
MARCKS (rat) EGAsASSTSSPKAED T126
MARCKS (chicken) gap -
MARCKS (cow) AASAASSTSSPKAED T132
S134-p
AsAAsstssPKAEDG
0 6
MARCKS (human) AsAAsstssPKAEDG S134-p
MARCKS (mouse) GAsAsstssPKAEDG S127-p
MARCKS (rat) GAsASSTSSPKAEDG S127
MARCKS (chicken) gap -
MARCKS (cow) ASAASSTSSPKAEDG S133
S135-p
sAAsstssPKAEDGA
0 11
MARCKS (human) sAAsstssPKAEDGA S135-p
MARCKS (mouse) AsAsstssPKAEDGA S128-p
MARCKS (rat) AsASSTSSPKAEDGA S128
MARCKS (chicken) SPAEGEASPKTEEGA S100
MARCKS (cow) SAASSTSSPKAEDGA S134
T143-p
PKAEDGAtPsPsNEt
0 17
MARCKS (human) PKAEDGAtPsPsNEt T143-p
MARCKS (mouse) PKAEDGAAPsPssEt A136
MARCKS (rat) PKAEDGAAPsPsSEt A136
MARCKS (chicken) PKTEEGATPSSSSET T108
MARCKS (cow) PKAEDGATPSPSNEt T142
S145-p
AEDGAtPsPsNEtPk
Upstream
0 53
Treatment
  • angiotensin_2
  • ischemia
  • nocodazole
MARCKS (human) AEDGAtPsPsNEtPk S145-p
MARCKS (mouse) AEDGAAPsPssEtPk S138-p
MARCKS (rat) AEDGAAPsPsSEtPK S138-p
MARCKS (chicken) TEEGATPSSSSETPK S110
MARCKS (cow) AEDGATPSPSNEtPK S144
S147-p
DGAtPsPsNEtPkkK
1 35
MARCKS (human) DGAtPsPsNEtPkkK S147-p
MARCKS (mouse) DGAAPsPssEtPkkK S140-p
MARCKS (rat) DGAAPsPsSEtPKKK S140-p
MARCKS (chicken) EGATPSSSSETPKKK S112
MARCKS (cow) DGATPSPSNEtPKKK S146
N148
GAtPsPsNEtPkkKK
0 7
MARCKS (human) GAtPsPsNEtPkkKK N148
MARCKS (mouse) GAAPsPssEtPkkKK S141-p
MARCKS (rat) GAAPsPsSEtPKKKK S141
MARCKS (chicken) GATPSSSSETPKKKK S113
MARCKS (cow) GATPSPSNEtPKKKK N147
T150-p
tPsPsNEtPkkKKKR
Upstream
1 77
Treatment
  • angiotensin_2
  • ischemia
  • nocodazole
MARCKS (human) tPsPsNEtPkkKKKR T150-p
MARCKS (mouse) APsPssEtPkkKKKR T143-p
MARCKS (rat) APsPsSEtPKKKKKR T143-p
MARCKS (chicken) TPSSSSETPKKKKKR T115
MARCKS (cow) TPSPSNEtPKKKKKR T149-p
K152-ub
sPsNEtPkkKKKRFs
0 2
MARCKS (human) sPsNEtPkkKKKRFs K152-ub
MARCKS (mouse) sPssEtPkkKKKRFs K145-ub
MARCKS (rat) sPsSEtPKKKKKRFs K145
MARCKS (chicken) SSSSETPKKKKKRFs K117
MARCKS (cow) SPSNEtPKKKKKRFs K151
K153-ub
PsNEtPkkKKKRFsF
0 2
MARCKS (human) PsNEtPkkKKKRFsF K153-ub
MARCKS (mouse) PssEtPkkKKKRFsF K146-ub
MARCKS (rat) PsSEtPKKKKKRFsF K146
MARCKS (chicken) SSSETPKKKKKRFsF K118
MARCKS (cow) PSNEtPKKKKKRFsF K152
S159-p
kkKKKRFsFkKsFkL
Upstream
Downstream
24 24
MARCKS (human)
S159-p
MARCKS (mouse)
S152-p
MARCKS (rat)
S152-p
MARCKS (chicken)
S124-p
MARCKS (cow)
S158-p
Effects on Biological Processes:
  • exocytosis, inhibited
Kinase, in vitro:
  • PKACA (cow)
  • PKCA (cow)
  • PKCA (human)
  • ROCK1 (human)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • angiotensin_2
  • ATP
  • bombesin
  • C3_toxin
  • dasatinib
  • EGF
  • eribulin
  • GF109203X
  • HA-1077
  • LPA
  • MANS_peptide
  • nocodazole
  • phorbol_ester
  • pleiotrophin
  • taxol
  • vincristine
MARCKS (human) kkKKKRFsFkKsFkL S159-p
MARCKS (mouse) kkKKKRFsFKKsFkL S152-p
MARCKS (rat) KKKKKRFsFKKsFkL S152-p
MARCKS (chicken) KKKKKRFsFKKsFKL S124-p
MARCKS (cow) KKKKKRFsFKKsFKL S158-p
K161-m1
KKKRFsFkKsFkLsG
0 1
MARCKS (human) KKKRFsFkKsFkLsG K161-m1
MARCKS (mouse) KKKRFsFKKsFkLsG K154
MARCKS (rat) KKKRFsFKKsFkLsG K154
MARCKS (chicken) KKKRFsFKKsFKLsG K126
MARCKS (cow) KKKRFsFKKsFKLsG K160
S163-p
KRFsFkKsFkLsGFs
Upstream
Downstream
22 37
MARCKS (human)
S163-p
MARCKS (mouse)
S156-p
MARCKS (rat)
S156-p
MARCKS (chicken)
S128-p
MARCKS (cow)
S162-p
Effects on Biological Processes:
  • exocytosis, inhibited
Kinase, in vitro:
  • PKCA (human)
  • PKCA (rat)
Putative in vivo kinases:
  • PKCA (human)
Treatment
  • bombesin
  • dasatinib
  • eribulin
  • GF109203X
  • ischemia
  • LRRK2-IN-1
  • MANS_peptide
  • nocodazole
  • phorbol_ester
  • pleiotrophin
  • taxol
  • vincristine
MARCKS (human) KRFsFkKsFkLsGFs S163-p
MARCKS (mouse) KRFsFKKsFkLsGFs S156-p
MARCKS (rat) KRFsFKKsFkLsGFs S156-p
MARCKS (chicken) KRFsFKKsFKLsGFs S128-p
MARCKS (cow) KRFsFKKsFKLsGFs S162-p
K165-ub
FsFkKsFkLsGFsFk
0 3
MARCKS (human) FsFkKsFkLsGFsFk K165-ub
MARCKS (mouse) FsFKKsFkLsGFsFK K158-ub
MARCKS (rat) FsFKKsFKLsGFsFk K158
MARCKS (chicken) FsFKKsFKLsGFsFK K130
MARCKS (cow) FsFKKsFKLsGFsFK K164
K165-ac
FsFkKsFkLsGFsFk
0 2
MARCKS (human) FsFkKsFkLsGFsFk K165-ac
MARCKS (mouse) FsFKKsFKLsGFsFK K158
MARCKS (rat) FsFKKsFkLsGFsFk K158-ac
MARCKS (chicken) FsFKKsFKLsGFsFK K130
MARCKS (cow) FsFKKsFKLsGFsFK K164
S167-p
FkKsFkLsGFsFkKN
Upstream
Downstream
6 54
MARCKS (human)
S167-p
MARCKS (mouse)
S160-p
MARCKS (rat)
S160-p
MARCKS (chicken)
S132-p
MARCKS (cow)
S166-p
Effects on Biological Processes:
  • exocytosis, inhibited
Kinase, in vitro:
  • PKCA (human)
  • PKCA (rat)
Treatment
  • angiotensin_2
  • EGF
  • ischemia
  • LRRK2-IN-1
  • nocodazole
  • SB202190
MARCKS (human) FkKsFkLsGFsFkKN S167-p
MARCKS (mouse) FKKsFkLsGFsFKKs S160-p
MARCKS (rat) FKKsFkLsGFsFkKS S160-p
MARCKS (chicken) FKKsFKLsGFsFKKN S132-p
MARCKS (cow) FKKsFKLsGFsFKKN S166-p
S170-p
sFkLsGFsFkKNKkE
Upstream
Downstream
10 168
MARCKS (mouse)
S163-p
MARCKS (rat)
S163-p
MARCKS (chicken)
S135-p
MARCKS (cow)
S169-p
Effects on Biological Processes:
  • exocytosis, inhibited
Kinase, in vitro:
  • PKCA (human)
Regulatory protein:
  • ANXA1 (human)
  • CYBA (human)
  • TBK1 (human)
Treatment
  • angiotensin-(1-7)
  • angiotensin_2
  • apocynin
  • EGF
  • ischemia
  • LRRK2-IN-1
  • metastatic potential
  • NAC
  • nocodazole
  • SB202190
  • U0126
  • WKYMVm
MARCKS (human) sFkLsGFsFkKNKkE S170-p
MARCKS (mouse) sFkLsGFsFKKsKKE S163-p
MARCKS (rat) sFkLsGFsFkKSKKE S163-p
MARCKS (chicken) sFKLsGFsFKKNKKE S135-p
MARCKS (cow) sFKLsGFsFKKNKKE S169-p
K172-ac
kLsGFsFkKNKkEAG
0 24
MARCKS (human) kLsGFsFkKNKkEAG K172-ac
MARCKS (mouse) kLsGFsFKKsKKEsG K165
MARCKS (rat) kLsGFsFkKSKKEAG K165-ac
MARCKS (chicken) KLsGFsFKKNKKEAG K137
MARCKS (cow) KLsGFsFKKNKKEAG K171
K172-sc
kLsGFsFkKNKkEAG
0 1
MARCKS (human) kLsGFsFkKNKkEAG K172-sc
MARCKS (mouse) kLsGFsFKKsKKEsG K165
MARCKS (rat) kLsGFsFKKSKKEAG K165
MARCKS (chicken) KLsGFsFKKNKKEAG K137
MARCKS (cow) KLsGFsFKKNKKEAG K171
K172-m1
kLsGFsFkKNKkEAG
0 1
MARCKS (human) kLsGFsFkKNKkEAG K172-m1
MARCKS (mouse) kLsGFsFKKsKKEsG K165
MARCKS (rat) kLsGFsFKKSKKEAG K165
MARCKS (chicken) KLsGFsFKKNKKEAG K137
MARCKS (cow) KLsGFsFKKNKKEAG K171
N174
sGFsFkKNKkEAGEG
0 2
MARCKS (human) sGFsFkKNKkEAGEG N174
MARCKS (mouse) sGFsFKKsKKEsGEG S167-p
MARCKS (rat) sGFsFkKSKKEAGEG S167
MARCKS (chicken) sGFsFKKNKKEAGEG N139
MARCKS (cow) sGFsFKKNKKEAGEG N173
K176-ub
FsFkKNKkEAGEGGE
0 1
MARCKS (human) FsFkKNKkEAGEGGE K176-ub
MARCKS (mouse) FsFKKsKKEsGEGAE K169
MARCKS (rat) FsFkKSKKEAGEGAE K169
MARCKS (chicken) FsFKKNKKEAGEGAE K141
MARCKS (cow) FsFKKNKKEAGEGGE K175
A178
FkKNKkEAGEGGEAE
0 7
MARCKS (human) FkKNKkEAGEGGEAE A178
MARCKS (mouse) FKKsKKEsGEGAEAE S171-p
MARCKS (rat) FkKSKKEAGEGAEAE A171
MARCKS (chicken) FKKNKKEAGEGAESE A143
MARCKS (cow) FKKNKKEAGEGGEAE A177
P234
EGAAGGDPQEAKPQE
0 1
MARCKS (human) EGAAGGDPQEAKPQE P234
MARCKS (mouse) EGAAGGEPREAEAAE P218
MARCKS (rat) EGAEGGEsREAEAAE S218-p
MARCKS (chicken) AKEEAGDSQEAKSDE S202
MARCKS (cow) EGAAGGDPQEAKPEE P236
K248-m1
EAAVAPEkPPAsDET
0 1
MARCKS (human) EAAVAPEkPPAsDET K248-m1
MARCKS (mouse) AEPEQPEQPEQPAAE Q231
MARCKS (rat) AEPEQPEQPEQPAAE Q231
MARCKS (chicken) gap -
MARCKS (cow) EAAVAPEKPPASEEA K250
S252-p
APEkPPAsDETKAAE
0 1
MARCKS (human) APEkPPAsDETKAAE S252-p
MARCKS (mouse) EQPEQPAAEEPQAEE A237
MARCKS (rat) EQPEQPAAEEPRAEE A237
MARCKS (chicken) AAPEKATGEEAPAAE G217
MARCKS (cow) APEKPPASEEAKAVE S254
S262-p
TKAAEEPsKVEEkKA
0 5
MARCKS (human) TKAAEEPsKVEEkKA S262-p
MARCKS (mouse) EPQAEEQsEAAGEKA S246-p
MARCKS (rat) EPRAEEPSEAVGEKA S246
MARCKS (chicken) APAAEEQQQQQQQEK Q227
MARCKS (cow) AKAVEEPSKAEEKAE S264
K267-ub
EPsKVEEkKAEEAGA
0 1
MARCKS (human) EPsKVEEkKAEEAGA K267-ub
MARCKS (mouse) EQsEAAGEKAEEPAP E251
MARCKS (rat) EPSEAVGEKAEEPAP E251
MARCKS (chicken) EQQQQQQQEKAAEEA Q232
MARCKS (cow) EPSKAEEKAEEAGVS K269
S314-p
SSACAAPsQEAQPEC
0 2
MARCKS (human) SSACAAPsQEAQPEC S314-p
MARCKS (mouse) ASAAPAASPEPQPEC S291
MARCKS (rat) ASAAPSAsPEPQPEC S291-p
MARCKS (chicken) gap -
MARCKS (cow) SSACAAPSQEAQPEC S315
S322
QEAQPECSPEAPPAE
0 1
MARCKS (human) QEAQPECSPEAPPAE S322
MARCKS (mouse) PEPQPECSPEAPPAP S299
MARCKS (rat) PEPQPECsPEAPPAP S299-p
MARCKS (chicken) QEAPSESSPEGPAEP S272
MARCKS (cow) QEAQPECSPEAPPAE S323